List of Tables
Table 1. Global Market Epilepsy Drugs Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Epilepsy Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Epilepsy Drugs Market Size Share by Region (2018-2023)
Table 4. Global Epilepsy Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Epilepsy Drugs Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Epilepsy Drugs Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Epilepsy Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Epilepsy Drugs Revenue Market Share by Type (2018-2023)
Table 9. Global Epilepsy Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Epilepsy Drugs Revenue Market Share by Type (2024-2029)
Table 11. North America Epilepsy Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Epilepsy Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Epilepsy Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Epilepsy Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Epilepsy Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Epilepsy Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Epilepsy Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Epilepsy Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Epilepsy Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Epilepsy Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Epilepsy Drugs Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Epilepsy Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Epilepsy Drugs Revenue Market Share by Application (2018-2023)
Table 24. Global Epilepsy Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Epilepsy Drugs Revenue Market Share by Application (2024-2029)
Table 26. North America Epilepsy Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Epilepsy Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Epilepsy Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Epilepsy Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Epilepsy Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Epilepsy Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Epilepsy Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Epilepsy Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Epilepsy Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Epilepsy Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Epilepsy Drugs Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Epilepsy Drugs Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Epilepsy Drugs as of 2022)
Table 39. Date of Key Players Enter into Epilepsy Drugs Market
Table 40. Global Epilepsy Drugs Key Players Headquarters and Area Served
Table 41. Epilepsy Drugs Product Solution and Service
Table 42. Global Epilepsy Drugs Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Abbott Laboratories Basic Information List
Table 45. Abbott Laboratories Description and Business Overview
Table 46. Abbott Laboratories Epilepsy Drugs Products, Services and Solutions
Table 47. Revenue (US$ Million) in Epilepsy Drugs Business of Abbott Laboratories (2018-2023)
Table 48. Abbott Laboratories Recent Developments
Table 49. GlaxoSmithKline Plc Basic Information List
Table 50. GlaxoSmithKline Plc Description and Business Overview
Table 51. GlaxoSmithKline Plc Epilepsy Drugs Products, Services and Solutions
Table 52. Revenue (US$ Million) in Epilepsy Drugs Business of GlaxoSmithKline Plc (2018-2023)
Table 53. GlaxoSmithKline Plc Recent Developments
Table 54. UCB Basic Information List
Table 55. UCB Description and Business Overview
Table 56. UCB Epilepsy Drugs Products, Services and Solutions
Table 57. Revenue (US$ Million) in Epilepsy Drugs Business of UCB (2018-2023)
Table 58. UCB Recent Developments
Table 59. Cephalon Basic Information List
Table 60. Cephalon Description and Business Overview
Table 61. Cephalon Epilepsy Drugs Products, Services and Solutions
Table 62. Revenue (US$ Million) in Epilepsy Drugs Business of Cephalon (2018-2023)
Table 63. Cephalon Recent Developments
Table 64. Johnson & Johnson Basic Information List
Table 65. Johnson & Johnson Description and Business Overview
Table 66. Johnson & Johnson Epilepsy Drugs Products, Services and Solutions
Table 67. Revenue (US$ Million) in Epilepsy Drugs Business of Johnson & Johnson (2018-2023)
Table 68. Johnson & Johnson Recent Developments
Table 69. Pfizer Basic Information List
Table 70. Pfizer Description and Business Overview
Table 71. Pfizer Epilepsy Drugs Products, Services and Solutions
Table 72. Revenue (US$ Million) in Epilepsy Drugs Business of Pfizer (2018-2023)
Table 73. Pfizer Recent Developments
Table 74. Novartis AG Basic Information List
Table 75. Novartis AG Description and Business Overview
Table 76. Novartis AG Epilepsy Drugs Products, Services and Solutions
Table 77. Revenue (US$ Million) in Epilepsy Drugs Business of Novartis AG (2018-2023)
Table 78. Novartis AG Recent Developments
Table 79. Abbvie Basic Information List
Table 80. Abbvie Description and Business Overview
Table 81. Abbvie Epilepsy Drugs Products, Services and Solutions
Table 82. Revenue (US$ Million) in Epilepsy Drugs Business of Abbvie (2018-2023)
Table 83. Abbvie Recent Developments
Table 84. Janssen Pharmaceuticals Basic Information List
Table 85. Janssen Pharmaceuticals Description and Business Overview
Table 86. Janssen Pharmaceuticals Epilepsy Drugs Products, Services and Solutions
Table 87. Revenue (US$ Million) in Epilepsy Drugs Business of Janssen Pharmaceuticals (2018-2023)
Table 88. Janssen Pharmaceuticals Recent Developments
Table 89. Sunovion Pharmaceuticals Basic Information List
Table 90. Sunovion Pharmaceuticals Description and Business Overview
Table 91. Sunovion Pharmaceuticals Epilepsy Drugs Products, Services and Solutions
Table 92. Revenue (US$ Million) in Epilepsy Drugs Business of Sunovion Pharmaceuticals (2018-2023)
Table 93. Sunovion Pharmaceuticals Recent Developments
Table 94. Bausch Health Basic Information List
Table 95. Bausch Health Description and Business Overview
Table 96. Bausch Health Epilepsy Drugs Products, Services and Solutions
Table 97. Revenue (US$ Million) in Epilepsy Drugs Business of Bausch Health (2018-2023)
Table 98. Bausch Health Recent Developments
Table 99. Sanofi S.A Basic Information List
Table 100. Sanofi S.A Description and Business Overview
Table 101. Sanofi S.A Epilepsy Drugs Products, Services and Solutions
Table 102. Revenue (US$ Million) in Epilepsy Drugs Business of Sanofi S.A (2018-2023)
Table 103. Sanofi S.A Recent Developments
Table 104. Takeda Basic Information List
Table 105. Takeda Description and Business Overview
Table 106. Takeda Epilepsy Drugs Products, Services and Solutions
Table 107. Revenue (US$ Million) in Epilepsy Drugs Business of Takeda (2018-2023)
Table 108. Takeda Recent Developments
Table 109. Eisai Basic Information List
Table 110. Eisai Description and Business Overview
Table 111. Eisai Epilepsy Drugs Products, Services and Solutions
Table 112. Revenue (US$ Million) in Epilepsy Drugs Business of Eisai (2018-2023)
Table 113. Eisai Recent Developments
Table 114. F. Hoffmann-La Roche Basic Information List
Table 115. F. Hoffmann-La Roche Description and Business Overview
Table 116. F. Hoffmann-La Roche Epilepsy Drugs Products, Services and Solutions
Table 117. Revenue (US$ Million) in Epilepsy Drugs Business of F. Hoffmann-La Roche (2018-2023)
Table 118. F. Hoffmann-La Roche Recent Developments
Table 119. North America Epilepsy Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 120. North America Epilepsy Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 121. Europe Epilepsy Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 122. Europe Epilepsy Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 123. Asia-Pacific Epilepsy Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 124. Asia-Pacific Epilepsy Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 125. Asia-Pacific Epilepsy Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 126. Asia-Pacific Epilepsy Drugs Market Share by Region (2018-2023)
Table 127. Asia-Pacific Epilepsy Drugs Market Share by Region (2024-2029)
Table 128. Latin America Epilepsy Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 129. Latin America Epilepsy Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 130. Latin America Epilepsy Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 131. Middle East & Africa Epilepsy Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 132. Middle East & Africa Epilepsy Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 133. Middle East & Africa Epilepsy Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 134. Epilepsy Drugs Market Trends
Table 135. Epilepsy Drugs Market Drivers
Table 136. Epilepsy Drugs Market Challenges
Table 137. Epilepsy Drugs Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Epilepsy Drugs Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Epilepsy Drugs Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Epilepsy Drugs Market Share by Regions: 2022 VS 2029
Figure 4. Global Epilepsy Drugs Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Epilepsy Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Epilepsy Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Epilepsy Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Epilepsy Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Epilepsy Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of First Generation
Figure 11. Global First Generation Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Second Generation
Figure 13. Global Second Generation Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Global Epilepsy Drugs Market Size Share by Type: 2022 & 2029
Figure 15. North America Epilepsy Drugs Revenue Market Share by Type (2018-2029)
Figure 16. Europe Epilepsy Drugs Revenue Market Share by Type (2018-2029)
Figure 17. Asia-Pacific Epilepsy Drugs Revenue Market Share by Type (2018-2029)
Figure 18. Latin America Epilepsy Drugs Revenue Market Share by Type (2018-2029)
Figure 19. Middle East and Africa Epilepsy Drugs Revenue Market Share by Type (2018-2029)
Figure 20. Hospital Pharmacies Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 21. Retail Pharmacies Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 22. Online Pharmacies Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 23. Global Epilepsy Drugs Market Size Share by Application: 2022 & 2029
Figure 24. North America Epilepsy Drugs Revenue Market Share by Application (2018-2029)
Figure 25. Europe Epilepsy Drugs Revenue Market Share by Application (2018-2029)
Figure 26. Asia-Pacific Epilepsy Drugs Revenue Market Share by Application (2018-2029)
Figure 27. Latin America Epilepsy Drugs Revenue Market Share by Application (2018-2029)
Figure 28. Middle East and Africa Epilepsy Drugs Revenue Market Share by Application (2018-2029)
Figure 29. Epilepsy Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 30. Global Top 5 and Top 10 Players Epilepsy Drugs Market Share in 2022
Figure 31. North America Epilepsy Drugs Market Share by Country (2018-2029)
Figure 32. U.S. Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
Figure 33. Canada Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
Figure 34. Germany Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
Figure 35. France Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
Figure 36. U.K. Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
Figure 37. Italy Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
Figure 38. Russia Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
Figure 39. Nordic Countries Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
Figure 40. Asia-Pacific Epilepsy Drugs Market Share by Region (2018-2029)
Figure 41. China Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
Figure 42. Japan Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
Figure 43. South Korea Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
Figure 45. India Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
Figure 46. Australia Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
Figure 47. Latin America Epilepsy Drugs Market Share by Country (2018-2029)
Figure 48. Mexico Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
Figure 49. Brazil Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Epilepsy Drugs Market Share by Country (2018-2029)
Figure 51. Turkey Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
Figure 53. UAE Epilepsy Drugs Market Size (2018-2029) & (US$ Million)
Figure 54. Bottom-up and Top-down Approaches for This Report